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BDS   Common Bile duct stone 
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ABSTRACT 
 
BACKGROUND AND OBJECTIVE 
 Gall Stone disease is a common clinical entity affecting adult population of 
both sexes. The old saying, that gall stone sufferer is a fat, fertile, female of fifty 
is only partly true, as the disease has been observed in women after their first 
delivery and also in underweight and thin people. Several etiological factors have 
been studied in the formation of gall stones. There has been recent interest in 
establishing the role of several nutritional trace elements in the pathogenesis of 
gall stone disease. 
 Iron Deficiency is a new and particularly interesting parameter which has 
been studied lately, but with a few studies showing conflicting results. 
Establishing the role of Serum Iron in the etiology of Gall stones is of special 
importance in our population group because of the huge prevalence of nutritional 
deficiencies. It also provides scope for early detection, treatment and risk 
modification if its role as an etiologic/risk factor is clearly defined. 
 
AIM: 
The study is aimed at establishing the role of iron deficiency in the super 
saturation of bile with respect to cholesterol, which leads to gall stone formation. 
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METHODS 
A study was done between December 2014 to September 2015 at the 
department of General Surgery.50 patients suffering from Cholelithiasis, 
confirmed by USG, were divided into two groups based on serum iron values. 
Group A, consists of patients with normal serum iron (non-anaemic) and group B, 
of patients with less than normal serum iron (anaemic). Serum Iron, Biliary 
Cholesterol and Serum Cholesterol of all the patients was obtained. The Biliary 
cholesterol levels and Serum cholesterol levels of both the groups was analysed 
by using a student t-test. 
 
RESULTS 
Out of the 50 Patients, 40 (80%) were female and 10 (20%) were males. 
The female to male ratio was 4:1. The Biliary Cholesterol values for Group 
A and B respectively were 754.5 ± 398.3 and 1184.7 ± 405.2 mg/dl. The 
Biliary Cholesterol levels were significantly higher in the Iron Deficient 
group (Group B) than compared to the Non-Iron Deficient Group. This 
result was extremely statistically significant with a p value of <0.0004. 
Similarly, an independent t-test comparing Serum Cholesterol levels in 
Non-Iron Deficient (184.8 ± 35 mg/dl) and Iron Deficient subjects (171 ± 
49.3 mg/dl) did not find a statistically significant difference. (p=0.2544). 
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CONCLUSION: 
These results suggest that Iron Deficiency has an association with Biliary 
Cholesterol Levels. 
 
KEY-WORDS: Biliary Cholesterol, Iron Deficiency, Gall Stone Disease 
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INTRODUCTION 
 
Gall Stone disease is a common clinical entity affecting adult population of 
both sexes. The old saying, that gall stone sufferer is a fat, fertile, female of fifty 
is only partly true, as the disease has been observed in women after their first 
delivery and also in underweight and thin people[1]. Several etiological factors 
have been studied in the formation of gall stones. There has been recent interest in 
establishing the role of several nutritional trace elements in the pathogenesis of 
gall stone disease.[2] 
Cholesterol gallstones occur most commonly in multiparous women, but 
the causes for this phenomenon remain unclear[3]. This same patient population is 
prone to chronic iron deficiency anemia. With this as the background, Iron 
Deficiency is a new and particularly interesting parameter which has been studied 
lately, but with a few studies showing conflicting results. In experimental data 
from adult prairie dogs,[4] Iron deficiency has been shown to alter the activity of 
several hepatic enzymes, leading to increased gall bladder bile cholesterol 
saturation and promotion of cholesterol crystal formation. Iron acts as a coenzyme 
for nitric oxide synthetase (NOS), and that is important for the maintenance of 
basal gall bladder tone and normal relaxation[5]. It was found that iron deficiency 
resulted in altered motility of gall and sphincter of oddi (SO), leading to biliary 
stasis and thus increased cholesterol crystal formation in the gall bladder bile.[6] 
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 Therefore, we tested the hypotheses that iron deficiency would alter hepatic 
cholesterol metabolism causing increased biliary cholesterol saturation and hence 
enhance gallstone formation. Establishing the role of Serum Iron in the etiology of 
Gall stones is of special importance in our population group because of the huge 
prevalence of nutritional deficiencies. It also provides scope for early detection, 
treatment and risk modification if its role as an etiologic/risk factor is clearly 
defined. 
 The present study was conducted on the randomly selected individuals of 
the South Indian Population, suffering from gall stone formation, to study the role 
of iron deficiency anaemia in gall stone formation. 
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AIMS OF THE STUDY 
 
The study is aimed at: 
PRIMARY: 
1. Determining the association of iron deficiency in the super saturation 
of bile with respect to cholesterol. 
SECONDARY: 
1. Determining the association of iron deficiency with serum cholesterol 
levels. 
2. Sex and Parity specific distributions in the serum iron levels and their 
correlation with biliary cholesterol levels 
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REVIEW OF LITERATURE 
 
3.1. BACKGROUND 
Cholelithiasis, is a medical term that literally means stones in the Gall 
Bladder. Gallstones are solid precipitants that form in the biliary tract, most 
commonly in the Gall Bladder, though its presence can be in any part of the 
biliary tract which includes the Common bile duct (referred to as 
Choledocholithiasis) and also the intra hepatic biliary radicles. 
Most cases of Gall Stones develop insidiously and may remain 
asymptomatic for a long time[7]. The principle etiological factors leading on to the 
development of Gall Stones are varied and have been extensively studied. These 
etiological factors also vary according to the type of gall stones with respect to 
their composition. These will be dealt with, in detail, in the following review. 
The principle cause of concern in cases of Gall Stone disease is that a 
percentage of these patients may develop symptoms typically referred to as 
Biliary colic. This is mostly due to the migration and blocking of the cystic ductal 
outflow by the gall stone. If this process persists for more than few hours, an acute 
inflammation of the gall bladder sets in which is referred to as Acute 
Cholelithiasis[8]. 
There is a Chronic phase of Cholecystitis which results due to repeated or 
subacute inflammation, which predominantly shows features of progressive 
fibrosis and a dysfunctional Gallbladder[8]. 
 
 5 
There are many imaging modalities that are used to diagnose Gall Stones, 
the most common being Ultrasonography[9]. Likewise, the treatment depends on 
the timing and severity of presentation. 
This Review of Literature begins with a Historical note on the problem of 
Gall Stones. The Anatomy and Physiology of Gallbladder is discussed. An 
epidemiological picture of the burden of this disease is stated. The discussion 
turns towards the pathophysiology of gallstones including the various types, and 
all the etiological/risk factors are discussed in detail. There is particular mention 
of the role of dietary micronutrients especially iron and its mechanism in 
formation of gallstones. 
From a clinical perspective, the typical presentation, work-up including 
relevant investigations and imaging modalities are discussed. Lastly, the 
management of Gallstone disease both from a medical and surgical perspective, 
including risk factor modification is dealt with. 
3.2. HISTORICAL NOTE 
 Gallstones disease has been prevalent even since time of ancient 
civilizations. There have been records of gall stones found even in Egyptian 
mummies. This confirms that cholelithiasis has plagued mankind for over 2000 
years[10].  
 Gordon Taylor (1937) suggested that the first clinical description of 
gallstone disease was recorded in the 4th century BC. Despite description of liver 
and gallbladder, recognition of the gallstones was not recorded until 5th century. 
The Greek physician Trallianus studied and reported stones within radicles of a 
human liver [11].  
 Vesalius and Fallopius later noted gallstones in dissected human bodies[12]. 
Joenisius was credited for the first successful cholecystolithotomy in 1676, but the 
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apparently extracted gallstones from a biliary fistula of the abdominal wall 
following spontaneous drainage of the abscess[13].  
 Cholecystotomy was reported and recommended by Jean- Louis Petit in 
1743 after he had mistakenly opened the gall bladder when attempting to drain 
what he thought was an abdominal wall abscess[14]. 
 Nonetheless, the treatment for symptomatic gallstone disease remained 
relatively primitive and ineffective until the late 1800’s. As surgical techniques 
began to evolve, John Bobbs, an Indian surgeon and others attempted to perform 
cholecystolithotomy, removing the stone from the gallbladder and leaving the 
organ in situ[15].  This proved to be effective in ameliorating acute symptoms, 
physicians were disappointed by the recurrence of symptoms in many of these 
patients. 
 In 1882, Langenbuch performed the first successful cholecystectomy, 
setting the path for therapeutic intervention in cholelithiasis[16].  
 For the next 100 years open cholecystectomy was the gold standard for 
definitive management of patients with symptomatic gall stones[17], until the 
advent of laparoscopy. 
3.2.1 RISE OF LAPAROSCOPIC CHOLECYSTECTOMY: 
Although these advances had widespread rise of laparoscopy for diagnostic 
and stabilization procedures in gynecological surgery, few general surgeons used 
it on their surgical practice. The exceptions were pioneering individuals such as 
George Berci and Alfred Cushiri who used diagnostic laparoscopy for everlasting 
and staging patients with abdominal malignancies. 
In 1987, Philippe Mouret performed the first laparoscopic cholecystectomy 
in a human[18]. Almost simultaneously Mc Kernan and Saye performed the first 
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laparoscopic cholecystectomy in the United States in 1988[19]. 
In fact, in 1985, Prof. Erich Muhe of Boblingen, Germany had carried out 
the first laparoscopic cholecystectomy. He presented his technique at the 
Congress of the German Surgical Society[20].Unfortunately, his technique was not 
appreciated by his colleagues and did not become popular. His work was not 
realized until 1999, when he was recognized by SAGES for having performed the 
first laparoscopic cholecystectomy. 
The first laparoscopic cholecystectomy in India was performed in 1990 at 
the JJ Hospital, Mumbai, followed by few months later in Pune by Dr. Jyotsna 
Kulkarni[21].Within a short span of five years laparoscopic cholecystectomy has 
surpassed conventional cholecystectomy as procedure of choice for diseases of 
gallbladder[22]. 
Thus a good amount of evidence is available that man in various areas of 
the world has suffered from calculous biliary tract disease even before the era 
when history was first recorded. The current treatment of this condition which, 
now accepted to be surgical is a development of the last 100 years[23]. The control 
and/or prevention of this pathological condition in the future is to be expected. 
The general course of events in man's conquest of his diseases has followed a 
rather consistent pattern. First, there has been the discovery and description of 
pathology; second, the definition of the alterations of physiology; and third, the 
correlation of these with the clinical manifestations and the complaints and 
symptoms of the patient.[11] 
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3.3 EMBRYOLOGY[24-26] 
 At 3rd week when the embryo is 3mm in length an endodermal bud arises 
from the ventral aspect of the gut at the point between for foregut and midgut. 
This endodermal bud enlarges and divides into pars hepatica and pars cystica. It 
passes through the septum transversum and grows into ventral mesogastrium. 
Cranial portion that is pass hepatica and caudal portion pass cystica. 
 Pars cystica develops into gall bladder and cystic duct. 
  Pars hepatica cells grows into the transverse septum 
 At 12th week of gestation liver function starts and cystic duct 
joins the hepatic duct and forms common bile duct (CBD). 
 
 
 
 
 
Figure 1. Embryological Development 
 
3.4  ANATOMY OF THE BILIARY SYSTEM 
The anatomy of the biliary tract can be divided into various segments, 
including the intrahepatic ducts, the extrahepatic ducts, the gallbladder and cystic 
duct, and the sphincter of Oddi[27]. 
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3.4.1 Intrahepatic Ducts 
The anatomy of the intrahepatic ducts is intimately associated with the 
anatomy of the liver. The lobar and segmental anatomy of the liver is determined 
by the sequential branching of the portal vein, hepatic artery, and biliary tree as 
they enter the parenchyma at the hilum[28]. All three of these structures follow 
roughly parallel courses and bifurcate just before entering the liver. This major 
bifurcation divides the liver into left and right lobes. According to Couinaud’s 
classification[29], the caudate lobe is segment I; segments II to IV are on the left; 
and segments V to VIII are on the right. 
 
 
 
 
 
  
 
Figure 2. Segmental biliary drainage of the liver 
 
 The biliary drainage of the right and left liver is into the right and left 
hepatic ducts, respectively. The left hepatic duct is formed within the umbilical 
fissure from the union of the three segmental ducts draining the left side of the 
liver (segments II through IV). The left hepatic duct crosses the base of segment 
IV (medial segment of the left lobe) in a horizontal direction to join the right 
hepatic duct and form the common hepatic duct. The right hepatic duct drains 
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segments V through VIII and is formed from the union of the right posterior and 
right anterior segmental ducts. The right posterior segmental duct is formed by the 
confluence of ducts draining segments VI and VII. The posterior segmental duct 
initially courses in a nearly horizontal direction before descending in a more 
vertical direction to join the anterior segmental duct. The right anterior segmental 
duct is formed by the union of the ducts draining segments V and VIII. In 
approximately 15% to 20% of cases, the right posterior duct drains into the left 
hepatic duct.[30] The biliary drainage of the caudate lobe (segment I) is variable.[31] 
In approximately 80% of the individuals, the caudate lobe drains into both the 
right and left hepatic ducts. In 15% of cases, the caudate lobe drains only into the 
left hepatic duct, and in the remaining 5% of cases, the caudate is drained 
exclusively by the right hepatic duct.[32] 
3.4.2 Extrahepatic Ducts 
Most patients have a bifurcation where the right and left hepatic ducts join 
to form the common hepatic duct. This junction may occur as a wide or an acute 
angle, or the two hepatic ducts may run parallel to each other before joining. In 
some patients, three hepatic ducts join to form the common hepatic duct. Usually, 
the hepatic ducts meet just outside of the liver parenchyma, with the cystic duct 
entering 2 to 3 cm distally[33]. Occasionally, the two hepatic ducts do not unite 
until after the cystic duct has joined the right hepatic duct. The common hepatic 
duct extends for a variable length from the junction of the right and left hepatic 
ducts to the entrance of the cystic duct into the gallbladder. 
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Figure 3. Anatomic divisions of gallbladder and extrahepatic biliary tree. 
 
 The common bile duct is formed by the union of the cystic and common 
hepatic ducts. The common bile duct is approximately 8 cm in length, but, like the 
hepatic duct, it varies in length according to the point of union of the cystic duct 
and the common hepatic duct. The normal diameter of the common bile duct 
ranges from 4 to 9 mm. The common bile duct is considered enlarged if the duct 
diameter exceeds 10 mm. The upper third, or supraduodenal portion, of the 
common bile duct courses downward in the free edge of the lesser omentum, 
anterior to the portal vein and to the right of the proper hepatic artery. The middle 
third, or retroduodenal portion, of the common bile duct passes behind the first 
portion of the duodenum, lateral to the portal vein and anterior to the inferior vena 
cava. The lower third, or intrapancreatic portion, of the common bile duct tra- 
verses the posterior aspect of the pancreas in a tunnel or groove to enter the 
second portion of the duodenum, where it is usually joined by the pancreatic duct. 
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The intramural or intraduodenal portion of the common bile duct passes obliquely 
through the duodenal wall to enter the duodenum at the papilla of Vater[27]. 
The relationship between the lower common bile duct and pancreatic duct 
is variable[34]: (1) the two structures may rarely unite outside the duodenal wall to 
form a long common channel; (2) the bile duct and pancreatic duct usually join 
within the duodenal wall to form a short common channel; or (3) the two 
structures may rarely enter the duodenum independently through separate orifices. 
The lower portion of the common bile duct and the terminal portion of the 
pancreatic duct are enveloped and regulated by a complex sphincter, the sphincter 
of Oddi. In 5% to 10% of patients who have pancreas divisum, the dorsal 
pancreatic duct enters the duodenum through an accessory sphincter, whereas the 
ventral pancreatic duct joins the common bile duct at the sphincter of Oddi. 
The extrahepatic bile ducts contain a columnar mucosa surrounded by a 
connective tissue layer. The surface is relatively flat, with basal nuclei and an 
absent or small nucleolus. The lamina propria consists of collagen, elastic fibers, 
and vessels. Occasional lymphocytes are found, and pancreatic acini and ducts 
may be seen in the wall of the intrapancreatic portion of the distal common bile 
duct. Muscle fibers in the bile duct are sparse and discontinuous. The muscle 
fibers that are present are usually longitudinal, although occasional circular fibers 
are observed. The distal common bile duct begins to develop a more substantial 
muscle layer in the intrapancreatic portion of the duct, which becomes prominent 
at the sphincter of Oddi, where distinct bundles of longitudinal and circular fibers 
are clearly identified. 
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3.4.3 Gallbladder and Cystic Duct 
The gallbladder is a pear-shaped organ that lies on the inferior surface of 
the liver at the junction of the left and right hepatic lobes between Couinaud’s 
segments IV and V .[35] The gallbladder varies from 7 to 10 cm in length and from 
2.5 to 3.5 cm in width. The gallbladder’s volume varies considerably, being large 
during fasting states and small after eating. A moderately distended gallbladder 
has a capacity of 50 to 60 mL of bile but may become much larger with certain 
pathologic states. The gallbladder has been divided into four areas: the fundus, 
body, infundibulum, and neck. Hartmann pouch is an asymmetric bulge of the 
infundibulum that lies close to the gallbladder’s neck. The neck points in a 
cephalad and dorsal direction to join the cystic duct[36]. 
 
 
 
 
 
 
 
 
 
Figure 4. Anatomic relations of gallbladder. 
 
The gallbladder wall consists of five layers[37]. The inner- most layer is the 
epithelium, and the other layers are the lamina propria, smooth muscle, 
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perimuscularsubserosal connective tissue, and serosa. The gallbladder has no 
muscularis mucosae or submucosa. Most cells in the mucosa are columnar cells, 
and their main function is absorption, but they also are capable of active 
secretion.[38] These cells are aligned in a single row, with slightly eosinophilic 
cytoplasm, apical vacuoles, and basal or central nuclei. 
The lamina propria contains nerve fibers, vessels, lymphatics, elastic fibers, 
loose connective tissue, and occasional mast cells and macrophages. The muscle 
layer is a loose arrangement of circular, longitudinal, and oblique fibers without 
well-developed layers. Ganglia are found between smooth muscle bundles. The 
subserosa is composed of a loose arrangement of fibroblasts, elastic and collagen 
fibers, vessels, nerves, lymphatics, and adipocytes. 
Rokitansky-Aschoff sinuses are invaginations of epithelium into the lamina 
propria, muscle, and subserosal connective tissue[39]. These sinuses are present in 
approximately 40% of normal gallbladders and are present in abundance in almost 
all inflamed gallbladders. The ducts of Luschka are tiny bile ducts found around 
the muscle layer on the hepatic side of the gallbladder. They are found in 
approximately 10% of normal gallbladders and have no relation to the 
Rokitansky-Aschoff sinuses or to cholecystitis. 
The cystic duct arises from the gallbladder and joins the common hepatic 
duct to form the common bile duct. The length of the cystic duct is variable, 
averaging between 2 and 4 cm. The cystic duct usually courses downward in the 
hepatoduodenal ligament to join the lateral aspect of the supraduodenal portion of 
the common hepatic duct at an acute angle.[30] Occasionally, the cystic duct may 
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join the right hepatic duct, or it may extend downward to join the retroduodenal 
duct[40]. In addition, the cystic duct may join the common hepatic duct at a right 
angle, may run parallel to the common hepatic duct, or may enter the common 
hepatic duct dorsally, on its left side, behind the duodenum, or, rarely, may enter 
the duodenum directly. The cystic duct contains a variable number of mucosal 
folds, similar to those found in the neck of the gallbladder. Although referred to as 
valves of Heister, these spiral folds do not have a valvular function. Variations in 
the length and course of the cystic duct and its point of union with the common 
hepatic duct are common. 
 In 1891, Calot described a triangular anatomic region formed by the 
common hepatic duct medially, the cystic duct laterally, and the cystic artery 
superiorly.[41]Calot triangle is considered by most to comprise the triangular area 
with an upper boundary formed by the inferior margin of the right lobe of the 
liver, rather than the cystic artery.[42]  A thorough appreciation of the anatomy of 
Calot triangle is essential during perfor- mance of a cholecystectomy because 
numerous important structures pass through this area. In most instances, the cystic 
artery arises as a branch of the right hepatic artery within the hepatocystic 
triangle. A replaced or aberrant right hepatic artery arising from the superior 
mesenteric artery usually courses through the medial aspect of the triangle, 
posterior to the cystic duct. 
Aberrant or accessory hepatic ducts also may pass through Calot triangle 
before joining the cystic duct or common hepatic duct. During performance of a 
cholecystectomy, clear visualization of the hepatocystic triangle is essential with 
accurate identification of all structures within this triangle. 
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Figure 5. The triangle of Calot and the hepatocystic triangle. 
 
3.4.4 Sphincter of  Oddi 
The entire sphincteric system of the distal bile duct and the pancreatic duct 
is commonly referred to as the sphincter of Oddi. This term is imprecise because 
the sphincter is subdivided into several sections and contains both circular and 
longitudinal fibers. The sphincter mechanism functions independently from the 
surrounding duodenal musculature and has separate sphincters for the distal bile 
duct, the pancreatic duct, and the ampulla. In more than 90% of the population, 
the common channel, where the biliary and pancreatic ducts join, is less than 1.0 
cm in length and lies within the ampulla. In the rare situation in which the 
common channel is longer than 1.0 cm or the biliary and pancreatic ducts open 
separately into the duodenum, pathologic biliary or pancreatic problems are likely 
to develop. The entire sphincter mechanism is actually composed of four 
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sphincters containing both circular and longitudinal smooth muscle fibers. The 
four sphincters are the superior and inferior sphincter choledochus, the sphincter 
pancreaticus, and the sphincter of the ampulla.[43] 
 
 
 
 
 
 
 
 
 
 
Figure 6. Anatomy of the Sphincter of Oddi 
 
3.4.5 Blood Supply 
Major blood supply is from cystic artery which is branch of right hepatic 
artery. It runs in Calot’s triangle closed to cystic duct. At the superior border of 
the neck of the gallbladder it divides into superficial and deep branches. 
Occasionally cystic artery may arise from hepatic artery proper or rarely from 
gastroduodenal artery. Cystic artery also supplies branches to hepatic ducts and 
upper part of common bile duct. Venous drainage is carried out by small veins 
which enter directly liver[44]. 
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Figure 7: Arterial blood supply of the gall bladder 
 
 
 
 
 
 
 
 
 
 
Figure 8: Arterial blood supply of the extrahepatic biliary tree 
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3.4.6 Lymphatics 
Proximally the lymphatic channels of the gallbladder communicate with 
those of Glisson‘s capsule of the liver which in turn drain into the thoracic duct 
through several channels. Distally the lymphatics from gallbladder and 
extrahepatic bile duct drain into the cystic lymph node, which is situated near the 
cystic artery origin from the right hepatic artery[45]. 
3.4.7 Nerve Supply 
Parasympathetic fibres of hepatic branch of anterior vagal trunk stimulate 
contraction of gallbladder and relax ampullary sphincter. Sympathetic fibres from 
cell bodies of coeliac ganglion inhibit contraction of gallbladder. The hormonal 
activity is much more important than neural function. 
Afferent pain fibres pass mainly through the right sympathetic fibres into 
the spinal segments T7-T9. This causes referred pain over the right infrascapular 
region. Some fibres may pass through the right phrenic nerve, C3-C5. 
Fibers from the right phrenic nerve travel by way of the phrenic, celiac, and 
hepatic plexuses to reach the gallbladder. Many of these fibers are afferent and 
may account for the pain referred to the right hypochondrium and radiating the 
back between the shoulder blades in some patients with gallbladder diseases[46]. 
Burnett and associates demonstrated three nerve plexuses: subserous, muscular, 
and mucosal. The ganglion cells in each nerve plexus decrease in number from 
subserous to mucosal levels. In comparison with the myenteric plexus of the gut, 
the subserous plexus ganglia are larger and spaced farther apart. 
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Figure 9: Nerve supply to the Extrahepatic Bile Tree. 
 
3.4.8 Anomalies of Gallbladder 
 The gallbladder may be septate, transversely or longitudinally placed. 
 The gallbladder may be double with a single cystic duct. 
 The gallbladder may be double with separate ducts opening into hepatic 
common or both ducts. The serosa may be separate or common. 
 Small ducts may connect gallbladder with liver. Usually these become 
obliterated. 
 The folded fundus (Phrygian cap) deformity is the commonest congenital 
abnormality of the gallbladder. It has no pathological significance, but 
when present it can be seen on cholecystectomy. 
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ANOMALIES OF THE GALLBLADDER[47] 
 
FORMATION 
 
 Phrygian cap 
 Bilobed gallbladder 
 Hourglass gallbladder. 
 Diverticulum of the gallbladder. 
 Rudimentary gallbladder 
NUMBER 
 
 Absence of the gallbladder 
(agenesis) 
 Duplication of the gallbladder 
POSITION 
 
 Floating gallbladder 
 Intrahepatic gallbladder 
 Left-sided gallbladder 
 Transverse gallbladder 
 Retrodisplaced gallbladder 
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ANOMALIES OF GALLBLADDER 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 - Anomalies of the gallbladder. A, Bilobed gallbladder. B, Hourglass 
gallbladder. C, Congenital diverticulum of the infundibulum.  
D, Septate gallbladder. 
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3.4.9 Variations of Cystic Duct Anatomy 
 
 
 
 
 
 
 
 
 
 
 
Figure 11[48]. 
A.  Low junction between the cystic duct and common hepatic duct. 
B.  Cystic duct adherent to the common hepatic duct. 
C.  High junction between the cystic and the common hepatic duct. 
D.  The cystic duct drains into right hepatic duct. 
E.  Long cystic duct that joins the common hepatic duct behind the duodenum. 
F.  Absence of the cystic duct. 
G.  The cystic duct crosses posterior to the common hepatic duct and joins it 
anteriorly. H. The cystic duct courses anterior to the common hepatic duct 
and joins it posteriorly. 
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3.4.10 Variations in the Arterial supply to the Gallbladder 
Variations in the arterial supply of the extrahepatic biliary tree are more 
common than variations in the ductal anatomy. Anatomic variations of the hepatic 
and cystic arteries are present in approximately 50% of individuals[32,49,50]. Based 
on their anatomic dissections, Benson and Page described three surgically 
important variations in the arterial anatomy.[49]  An accessory or double cystic 
artery occurs in approximately 15% to 20% of individuals.[49,51] These arteries 
usually arise from the right hepatic artery within Calot triangle. Triple cystic 
arteries are unusual and occur in less than 1% of individuals. During dissection of 
Calot triangle, care should be taken to exclude the presence of an accessory cystic 
artery[52]. 
In 5% to 15% of individuals, the right hepatic artery courses through Calot 
triangle in close proximity to the cystic duct before turning upward to enter the 
hilum of the liver.[49,50]In this location, the cystic artery arises from the convex 
aspect of the angled or humped portion of the hepatic artery. This “caterpillar 
hump” right hepatic artery may easily be mistaken for the cystic artery and may 
be inadvertently ligated during performance of a cholecystectomy. The cystic 
artery that arises from the caterpillar hump is typically short and may easily be 
avulsed from the hepatic artery if excessive traction is applied to the 
gallbladder.[49] 
The cystic artery may occasionally pass anterior to the common bile duct 
or common hepatic duct.[53] In this location, the cystic artery, rather than the cystic 
duct, is usually the first structure encountered during dissection of the lower 
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border of Calot triangle.[51] These arteries usually require ligation and division 
early in the dissection during a cholecystectomy, to provide adequate exposure of 
the cystic duct. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 . Vascular anomalies. A, A′, “Caterpillar hump” right hepatic artery. B, 
Right hepatic artery anterior to common hepatic (or common bile) duct. C, Cystic 
artery anterior to common hepatic (or common bile) duct. D,  
Accessory cystic artery. 
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3.5 PHYSIOLOGY OF GALLBLADDER 
Bile secretion by liver is an active and continuous process. Its expulsion 
into duodenum, which is its site of action, is intermittent. Hence, it is necessary 
for bile to be stored and to be released when needed. Gallbladder serves this main 
function. Strictly bile is not a digestive secretion, because it doesn't possess any 
digestive enzymes. Liver secretes bile at the rate of 40ml/hr. The sphincter of 
Oddi dictates the flow of bile[54]. 
 
 
 
 
 
 
 
 
Figure 13: The effect of cholecystokinin on the gallbladder and the  
Sphincter of Oddi.  
 
A. During fasting, with the sphincter of Oddi contracted and the gallbladder 
filling.  
B. In response to a meal, the sphincter of Oddi relaxed and the gallbladder 
emptying. 
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The functions of gallbladder are – 
•  Reservoir of bile 
•  Concentration of bile 
•  Pressure regulation 
•  Secretion of bile 
3.5.1 Mechanism of storage 
The CBD is shut off from duodenum by sphincter of Oddi when pressure 
exceeds >70 mm H2O, bile is directed from CBD into gallbladder. Because of 
inherent capacity of gallbladder to absorb water and inorganic constituents, bile is 
concentrated 4-10 times. 
3.5.2 Movements of gallbladder[16] 
•  Tonic contractions begin 5-30 minutes after food intake, intermittently till 
the gallbladder is empty. Normal emptying time varies between 2-5 hours 
•  Rhythmic contractions, which are weak, not exceeding 50mmH2O are not 
ableto expel bile into duodenum. Since this pressure is less than the secretory 
pressure of liver, filling and evacuation is entirely dependant upon reciprocal 
sphincter of Oddi contraction and relaxation. 
3.5.3 Mechanism in expulsion of bile[55] 
Expulsion of bile requires 2 factors  
-  increased pressure of bile 
-  relaxation of sphincter of Oddi. 
Pressure of bile is increased and secretion of bile is stimulated by bile acids and 
fatty meal. Gallbladder contraction is brought about by stimulation of right vagus, 
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which is motor to gallbladder and inhibitory to sphincter. Thesecond mechanism 
is hormonal which is more important than neural reflex. Cholecystokinin is 
secreted by duodenal mucosa, in response to food and low pH. The hormone has 
potent stimulative action on gallbladder and inhibitory action on sphincter of 
Oddi. 
3.5.4 Bile salts and Bile acids 
These are steroid molecules, formed from cholesterol by hepatocytes and 
are major pathway of cholesterol excretion by body. To enhance their solubility in 
bile, bile acids are conjugated with glycine and taurine before excretion as sodium 
salts. 
 Primary bile acids - cholic acid / cheno acid 
 Secondary bile acids - deoxycholic / lithocholic / 7 ketolithocholic acid  
 Tertiary bile acids -ursodeoxycholic acid 
 
3.5.5 Bile Pigments 
Bilirubin is the chief bile pigment, produced by the breakdown of 
senescent RBCs in reticuloendothelial system. Biliverdin is produced from 
bilirubin. 
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Figure 14[16]. Equilibrium phase diagram of a cholesterol– phospholipid 
(lecithin)–mixed bile salt system (37°C, 0.15 M NaCl, pH 7.0, total lipid 
concentration 7.5 g/dL) showing positions and configuration of crystallization 
regions. Components are expressed in moles percent. 
 
 The 1-phase micellar zone at the bottom is enclosed by a solid angulated 
line, and above it, 2 solid lines divide the two-phase zones from a central 3-phase 
zone. Based on the solid and liquid crystallization sequences present in the bile, 
the left two-phase and central three-phase regions are divided by dashed lines into 
regions A to D. The number of phases given represents the equilibrium state. The 
phases are cholesterol monohydrate crystals and saturated micelles for 
crystallization regions A and B; cholesterol monohydrate crystals, saturated 
micelles, and liquid crystals for regions C and D; and liquid crystals of variable 
composition and saturated micelles for region E. 
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3.6 GALLSTONE DISEASE 
3.6.1 Epidemiology: 
Gallstones are the most common biliary pathology. The incidence of 
biliary calculous disease varies widely throughout the world. By the age of 75, 
about 35% of women and 20% of men would have developed gallstones. The 
incidence of gallstone disease in Asia is considerable and constitutes a problem of 
enormous magnitude. The incidence of cholesterol gallstones is increasing in Asia 
for the reasons that may be related to environmental and dietary considerations. 
Most patients with gallstones are asymptomatic and only about 10% will 
have developed symptoms five years after discovery. In a functioning gall 
bladder, most of the gall stones are cholesterol stones. Gall stone disease is a 
relatively common problem in our country particularly in North India. It is 
estimated that more than sixty percent of these patients have cholesterol stones. 
Recent studies from south India have highlighted pigment and mixed variety of 
gall stones to be more common (> 90 %) in contrast to cholesterol stones. 
In India, there is a dual pattern of prevalence. Some studies have shown 
that North Indians are more prone to cholelithiasis than South Indians. The nature 
of the disease is also different in North India and South India. In North India, 
Cholesterol stones form the majority of gallstones. In contrast to this, pigment 
stones are more frequent in South India. 
A. True Incidence : 5-year incidence in women aged 30, 40, 50, and 60 are 
(4%), (3.6%), (3%) and (3.7%) years and the same incidence rate in men were 
0.3%, 2.9%, 2.5% and 3.3% at the same age. This shows that the incidence is 
more in women. 
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B. Prevalence and Incidence : Gallstones are two times more common in 
women than in men. 
C.  Ethnic Predisposition : Several genes that are associated with gallstone 
formation and resistance are identified in mice. The importance of these genes in 
human gallstone formation has not been established. Pima Indians in southern 
Arizona are an example of an extremely high risk population in which 70% of 
women less than 25 years are affected by the disease. Populations at the lowest 
risk are sub Saharan Africans and Asians. 
D. Risk Factors: Gallstone disease is multifactorial in origin and occur 
sporadically. Specific risk factors predisposing gallstones have been identified. 
These are discussed in detail. 
 
 
 
 
 
 
 
 
 
Figure 15. Prevalence rates of cholesterol gallstones  
by gender in 18 countries. 
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Figure 16. Prevalence of cholesterol gallstones around the world. 
3.6.2 Classification of gall stones[56] 
1) Pure gallstones 
• Cholesterol gallstones 70% 
•  Pigment gallstones 30% 
• Calcium carbonate gallstones 
2) Mixed and combined stones 
 
Cholesterol Gallstones:[57] 
10% gallstones are cholesterol stones. They are usually solitary with 
smooth surface, oval or round in shape, pale yellow in colour. They are thought to 
be formed in aseptic static bile and commonly found in Hartman’s pouch. On 
section they shows radiating lines crossing the circular strata. In combined 
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gallstone, the stone starts as pure cholesterol stones but ultimately receives mixed 
covering of pigment and cholesterol. 
Pigment Gallstones: 
May be pure or contain Calcium bilirubinate. They constitute about 80% of 
all gallstones. They are Dark or black brown in colour, found exclusively in the 
gallbladder associated with excessive haemolysis like hereditary spherocytosis, 
sickle cell disease, thalassemia etc. Excessive breakdown of hemoglobin resulting 
in increase bilirubin which are excreted in bile and forms pigment stones in the 
gallbladder. Stones are usually appear as small soft fatty like masses. 
Calcium bilirubinate stones are brown to orange in colour and soft in 
consistency. These stones are more often seen in bile ducts. These stones are often 
caused by infection (E.Coli and parasites). 
Calcium Carbonate Stones: 
Calcium carbonate stones are rarest type of stone they are grayish white in 
colour with smooth surface or articulated surface. Increase alkalinity of the bile 
favours this stone formation. 
Mixed or Combined Stones: 
Mixed stones have varying proportion of all three of the stone forming 
constituents of the bile eg. cholesterol, bile pigment and calcium. They constitute 
about 10% of gallstones. 
Combined stones are those in which central core or external layers are pure 
and the reminder of the stone is mixture of constituents. Combined stones may be 
solitary but mixed gallstones are invariably multiple with faceted surface. Stones 
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may vary in size few cm in diameter. Colour of the stone depends on constituents 
of stones. 
Pale yellow - Cholesterol 
Black - Calcium bilirubinate 
Grayish white - Calcium carbonate. 
 
 
 
 
 
 
 
 
 
 
 
On section of laminated central nucleus may contain epithelial debris and 
bacteria. This suggests inflammatory origin of stones. Chemical inflammatory 
changes prepare the soil for bacterial invasion. 
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3.6.3 Risk factors associated with gallstone formation[58]: 
1. Cholesterol stones 
 i. Age > 40 years 
 ii. Estrogens 
  a. Female sex (2-3 times the risk in men) 
  b. Pregnancy (risk increases with number of pregnancies)  
  c. Estrogen containing OCPs. 
 iii. Genetic or ethnic variation  
 iv. High fat, low fiber diet 
 v. Obesity 
 vi. Hyperlipidaemia 
 vii. Bile salt loss ( Ileal disease or resection; Crohn’s disease )  
 viii. Cystic fibrosis 
 ix. Anti-hyperlipidaemic drugs ( Clofibrate ) 
 x. Impaired gall bladder emptying 
  a. Truncalvagotomy 
  b. Type-1 diabetes 
  c. Octreotide 
  d. Total parenteral nutrition 
  e. Starvation or rapid voluntary weight loss 
2. Pigment stones 
 i. Haemolytic disease 
 ii. Biliary stasis 
 iii. Biliary infection 
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3.6.4 Description of Risk Factors   
1) Age and gender 
Gallstone disease increases with age. Hence bile become more lithogenic 
with increasing age. Most studies report that incidence and prevalence of 
gallstones is three to four fold higher in female. But after 50 years the incidence 
may become equal in male and females. This may be due to increase oestrogen in 
young women lead to increased secretion of cholesterol into bile[59]. 
2) Pathophysiology of gallstone formation with aging 
Changes in bile composition with aging accounts for an increase risk of 
cholesterol gallstone formation. Biliary cholesterol saturation index (CSI) rises 
with age in both men and women. An inverse relation was seen between the age 
and hepatic bile salt synthesis and activity of enzyme 7 α-hydroxylase (rate 
limiting enzyme for bile salt synthesis). 
Factors that change with the age like change in contraction of gallbladder, 
ability to concentrate bile are also incriminated in gallstone formation including 
pigment or mixed stones. 
3) Rapid weight loss 
The physiological alterations that lead to gallstone formation as a result of 
rapid weight loss are multiple. 
i. Hepatic cholesterol secretion increase during caloric restriction. 
ii. Increase secretion of mucin which is potent stimulator of cholesterol 
crystal formation. 
iii. Decrease gall bladder motility leading to biliary sludge formation. 
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Gallstone formation can be prevented by administration of 
ursodeoxycholicacid in these patients. It is also found that there is decrease in 
gallstone formation in obese persons who are taking low caloric diet[60]. 
4) Pathophysiology of gallstone formation in obese persons 
In obese persons hepatic cholesterol synthesis is increased and cholesterol 
saturation index (CSI) more. Gallbladder bile is supersaturated with cholesterol. 
Secretion of bile salts and phospholipids is either normal or increased. Gallbladder 
contractility may be decreased in the obese persons. So gallbladder stasis with 
supersaturated bile lead to gallstone formation. 
5) Pregnancy and Parity 
Due to increase eostrogen level bile became more lithogenic due to 
increase in cholesterol secretion and supersaturation of bile. Gallbladder volume 
will be doubled and stasis develops with formation of biliary sludge. Higher 
progesterone levels also impair gallbladder motility. 
Both biliary sludge and stones are silent in nature but it may become 
symptomatic. After delivery in 60-70% pregnant woman biliary sludge disappears 
and gallstones disappears in 20-30%[61]. 
6) Drugs 
Drugs which increases the gallstone formation are oestrogens, oral 
contraceptives, clofibrate, octreotide, cefriaxone (third generation 
cephalosporin)[62]. 
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7) Systemic diseases 
Gallstone formation is common in diabetic persons and its complications 
are also more. Insulin resistant diabetes mellitus is associated with 
hypertriglyceridemia, obesity, hypomotility of gallbladder leading to biliary 
sludge formation which inturn may lead to gallstone formation. The prevalence of 
gallstones in persons who had spinal cord injury is about 31% and biliary 
complications occur in 2.2% Hence biliary stasis is likely the cause of gallstone 
formation. 
8) Cirrhosis of liver 
Gallstone formation is 2-3 times greater in cirrhotic patients than a non 
cirrhotic population at all ages[63]. In advanced cirrhosis there is marked reduction 
in bile salt secretion. It is stated that decrease in bile salt is matched by diminished 
biliary lecithin and cholesterol and bile is not lithogenic. Gallstone in cirrhosis 
and other chronic liver disease is usually due to chronic haemolysis and majority 
of the stones are pigment type. Jaundice in cirrhosis is more likely to be due to 
hepatic decompensation than a stone in the CBD. 
9) Ileal disease or resection: 
In Crohn’s disease with extensive involvement of ileum and major 
resection of ileum lead to malabsorption of bile salts. This inturn leads to 
increased cholesterol and supersaturated bile. Therefore gallstone formation is 
more. Gallstone are usually cholesterol type[64]. 
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10) Gastric surgery 
Gastric bypass surgery for peptic ulcers and for gross obesity is 
complicated with increase prevalence in gallstone formation[65]. Truncalvagotomy 
will adversely affect gallbladder emptying or bile lipid composition. 
11) Haemolytic anaemia 
Patients with haemolyticanaemia and hereditary spherocytosis is associated 
with increased incidence of pigment gallstone formation due to haemolysis[66]. 
12) Other conditions 
Children with cystic fibrosis have increased incidence of gallstones. 
Association with peptic ulcer and hyperparathyroidism – a firm evidence is not 
available. 
3.6.5 Description of Protective Factors 
1) Statins[67] 
Use of statins has been associated with a decreased risk of gallstone disease 
in 2 large case-control studies. The first study compared 27,035 patients with 
gallstone disease requiring cholecystectomy with 106,531 matched controls and 
showed a benefit to long-term statin use (>20 prescriptions filled and use of 
statins for >1.5 years); statin use was associ- ated with a decreased risk of 
gallstone disease requiring cholecystectomy (adjusted odds ratio [OR], 0.64). 
Similar results were observed in a population study from Denmark of 32,494 
patients with gallstone disease matched with 324,925 controls. The odds ratio of 
having gallstone disease in current and prior users of statins (>20 prescriptions 
filled) was 0.76 and 0.79, respectively, compared with controls. 
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2) Ascorbic acid[68] 
The observation that deficiency of ascorbic acid (vitamin C) is associated 
with development of gallstones in guinea pigs prompted investigation of the 
relationship between ascorbic acid levels and gallstones in humans. Serum 
ascorbic acid levels have been correlated with clinical or asymptomatic gall- 
stones in 7042 women and 6088 men who were enrolled in the Third National 
Health and Nutrition Examination Survey. Among women, but not men, each 
standard deviation increase in serum ascorbic acid levels was associated with a 
13% lower prevalence of clinical gallbladder disease. 
3) Coffee[69] 
In a 10-year follow up of 46,000 male health professionals, subjects who 
consistently drank 2 to 3 cups of regular coffee per day were approximately 40% 
less likely to develop symptomatic gallstones. Drinking 4 or more cups per day 
was even more beneficial (relative risk 0.55), but there was no benefit to drinking 
decaffeinated coffee. A similar benefit to regular coffee was noted in a cohort 
study involving 81,000 women. 
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3.7  PATHOPHYSIOLOGY OF GALL STONES 
Pathogenesis of gallstone is multifactorial. There are significant difference 
in etiology of cholesterol and pigment gallstone. This understanding of this factor 
is important to prevent the disease and for treatment modalities. Gallstones are 
concretions and aggregations that are formed as a result of imbalance between bile 
acids and cholesterol in the ratio 1:10. 
The Figure shows interactions of 5 primary defects that lead to formation 
of cholesterol gallstones[16]: (1) certain genetic factors, including LITH genes, (2) 
hepatic hypersecretion of biliary cholesterol, (3) gallbladder hypomotility, (4) 
rapid phase transitions of cholesterol, and (5) certain intestinal factors. These 
defects act together to facilitate cholesterol nucleation and crystallization, and 
ultimately promote formation of cholesterol gallstones. 
 
 
 
 
 
 
 
 
Figure 17. Venn diagram of 5 primary defects that work together to promote 
formation of cholesterol gallstones. The 5 defects are genetic factors and lith 
(gallstone) genes, gallbladder hypomotility, rapid phase transitions, hepatic 
hypersecretion of cholesterol, and intestinal factors 
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3.7.1 Stages of gallstone formation 
1) Cholesterol saturation[70] 
Cholesterol is not soluble in bile. Bile acids are amphipathic compounds 
with one end being hydrophilic and polar and other end being hydrophobic and 
nonpolar. These ionized molecules form micelles in dilute solutions with 
hydrophobic end inwards and hydrophilic end outwards. Incorporation of lecithin 
into the micelle allows H2O to penetrate the structure causing swelling. This 
process increase the ability of the micelle to transport greater amount of 
cholesterol. Recent information indicates that no more than 30% of cholesterol is 
transported in micelles. 
The relative amounts of cholesterol transported by vesicles and micelles is 
related to the degree of bile saturation and crystal precipitation and stone 
formation. Cholesterol super saturation can occur secondary to secretion of 
hepatic bile with increased amounts of cholesterol or increased amounts of bile 
acids or lecithin. 
Sequence of events in cholesterol stone synthesis includes - 
Nucleation[71] – Aggregation of cholesterol crystals with in a supersaturated bile 
solution. Cholesterol monohydrate crystals form and agglomerate to become 
macroscopic stones. Mucin is a pronucleating factor and act as a matrix on which 
crystals can conglomerate and clusterise. 
Stone growth– It is natural consequence of cholesterol precipitation and 
conglomeration. 
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2) Gallbladder factors 
Gallbladder contributes in gallstone formation by a complex interaction of 
muscular and mucosal events. 
a) Stasis[72] 
Gallbladder’s ability to empty is more slow and incomplete in cholelithiais. 
This muscle abnormality precedes gallstone formation and persists after the 
gallstone have been removed by dissolution therapy. This stasis is a feature of 
both cholesterol and pigment stones. Other factors are like sequestration of bile 
acids within the gallbladder reducing the amount of bile salts available for 
cholesterol solubalisation, alterations in the secretory or absorptive function of 
gallbladder leading to biliary stasis. 
b) Phospholipids in bile[73] 
Studies indicate that gallstone formation is accompanied by an increase in 
arachidonic acid containing phospholipids. Increased hydrolysis of arachidonyl 
lecithin provides the substrate for formation of prostanoids in the gallbladder wall. 
This activation of the prostanoid synthetic cascade is accompanied by reduced 
gallbladder motility and increase in mucin production by the gallbladder mucosa. 
c) Bile mucus glycoprotiens[74] 
The excessive production of glycoprotiens by gallbladder mucosa precedes 
stone formation. Mucin gel interferes with gallbladder contractility and emptying 
and acts as a nucleating matrix for cholesterol crystals to form cholesterol 
phospholipids vesicles. 
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d) Calcium[75] 
 Role of calcium is indicated by the presence of calcium salts in majority of 
gallstones. Preliminary results suggest that gallbladder bile from patients with 
cholesterol gallstones contain high levels of calcium. Mechanism by which biliary 
calcium increases the formation gallstones remains unknown but possible 
explanation includes enhanced absorption of water and solutes by the gallbladder 
and increase gallbladder secretion of calcium, or decrease absorption of calcium. 
Crystalline structures of calcium carbonate and cholesterol monohydrate crystals 
provide frame work for gallstone formation. In addition to the structural role, data 
suggests that calcium promotes fusion of vesicles and evaluates cholesterol crystal 
growth. 
3) Epitaxy[76] 
 This is the phenomenon of the growth of one compound in one or more 
particular orientation on the substrate of another with near geometrical fit between 
respective networks which are in contact. Studies have shown that expitaxial role 
plays a significant part in almost all cases. 
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Figure 18:Triangle of Solubility.With the three major components of bile that 
determine cholesterol solubility and stability, each can be quantified by molar % 
to show a relative ratio to the other two. Cholesterol is completely soluble in only 
the small area in the left lower corner, where a clear micellar solution exists, 
below the closed circles. Just above this, in the area between the open and closed 
circles, cholesterol is supersaturated but stable, and thus only crystallized with 
stasis. in the remainder of the triangle, cholesterol is significantly supersaturated 
and unstable. in this region, crystals form immediately. 
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Figure 19. Sequence of events in Cholesterol Lithogenesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.7.2 Pigment gallstones: 
This term is used for stones containing less than 25% cholesterol. They are 
irregular or smooth and amorphous or crystalline on cross-section. They represent 
quarter of gallstones removed at cholecystectomy. There are two types: black and 
brown. 
Black pigment stones are largely composed of an insoluble black pigment 
polymer mixed with calcium phosphate and carbonate. They are usually limited to 
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the gallbladder. They accompany chronic haemolysis, usually hereditary 
spherocytosis or sickle cell disease, and mechanical prostheses in the circulation. 
Brown Pigment Stones have calcium bilirubinate as their major 
component but calcium palmitate and cholesterol are other major constituents. 
They are usually radiolucent. They are found in the intra-hepatic and extra-hepatic 
bile ducts and in the gallbladder. They are virtually 10% associated with stricture, 
sclerosing cholangitis and Caroli’s syndrome. Recurrent bile duct stones are 
usually of this type.In Oriental countries, they are associated with parasitic 
infestations of the biliary tract such as Clonorchissinensis or Ascarislumbricoides. 
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3.8 CLINICAL FEATURES 
3.8.1 Clinical presentation of gallstones[77]: 
1.  Asymptomatic. 
2.  Biliary colic. 
i. Right subcostal or epigastric pain radiating to back or lower pole of 
scapula lasting for 20 minutes to 6 hours. 
ii.  Associated with vomiting, brought on by (any) food. 
iii. May disturb sleep. 
3.  Flatulent dyspepsia. 
4.  Acute Cholecystitis - Calculous (as opposed to Acalculous) / 
Empyema gallbladder 
Gangrenous Gallbladder: 
i. Severe pain and tenderness in right subcostal region - Murphy  sign 
- pain on palpation of the right upper quadrant when the patient 
inhales.  
ii. Fever and leucocytosis. 
5.  Chronic calculous Cholecystitis - repeated episodes of right 
hypochondrial pain with/without fever and vomiting. 
6.  Cholangitis - Fever with chills/rigors, transient jaundice, upper 
abdominal pain, vomiting - Charcot triad (right upper quadrant pain, 
fever, and jaundice) 
7.  Mucocele - Heaviness in upper abdomen; palpable lump.  
8.  Choledocholithiasis with extra-hepatic cholestasis. 
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9.  Biliary pancreatitis. 
10.  Gallstone ileus. 
11.  Gallbladder perforation.  
12.  Gallbladder carcinoma. 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Schematic depiction of the natural history and complications of 
gallstones. The percentages indicate the approximate frequencies of complications 
that occur in untreated patients, based on natural history data. The most frequent 
outcome is for the patient with a stone to remain asymptomatic throughout life 
(1). Biliary pain (2), acute cholecystitis (3), cholangitis (5), and pancreatitis (5) 
are the most common complications. Mirizzi's syndrome (4), cholecystoenteric 
fistula (6), Bouveret's syndrome (6), and gallbladder cancer (7) are relatively rare. 
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3.8.2 Symptomatic gallstones:  
1) Chronic calculous cholecystitis 
Ongoing inflammation with recurrent episodes of biliary colic or pain from 
cystic duct obstruction is referred to as chronic cholecystitis. Histologically, 
chronic cholecystitis is characterized by an increase in subepithelial and 
subserosal fibrosis and a mononuclear cell infiltrate. 
The primary symptom of chronic cholecystitis or symptomatic 
cholelithiasis is pain, often referred to as biliary colic. The pain is constant and 
usually lasts 1 to 5 hours. Other symptoms such as nausea and vomiting often 
accompany each episode, and bloating and belching may also be present in 50% 
of cases. Fever and jaundice are rare with simple biliary colic. During an episode 
of biliary colic, mild right upper quadrant tenderness may also be present. 
  An abdominal ultrasound is the standard diagnostic exam for gallstones. If 
the patient has recurrent attacks of typical biliary colic and sludge is detected on 
two or more occasions, cholecystectomy is indicated. In addition to sludge and 
stones, cholesterolosis and adenomyomatosis of the gallbladder may cause typical 
biliary symptoms and may be detected on ultrasonography. Cholesterolosis is 
caused by the accumulation of cholesterol in macrophages in the gallbladder 
mucosa, either locally or as polyps. It produces the classic macroscopic 
appearance of a “strawberry gallbladder.” 
The optimal treatment for patients with symptomatic cholelithiasis is 
elective laparoscopic cholecystectomy. Patients should be advised to avoid dietary 
fats and large meals while awaiting surgery. Diabetic patients should have a 
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cholecystectomy promptly because they are at higher risk for acute cholecystitis 
or even gangrenous cholecystitis.  
2) Acute calculous cholecystitis 
Acute cholecystitis is related to gallstones in 90% to 95% of cases. 
Obstruction of the cystic duct leading to biliary colic is the initial event in acute 
cholecystitis. If the cystic duct remains obstructed, the gallbladder distends, and 
the gallbladder wall then becomes inflamed and edematous. In the most common 
scenario, the gallstone dislodges, and the inflammation will gradually resolve. 
Right upper quadrant pain, similar in severity to but much longer in 
duration than pain from previous episodes of biliary colic, is the most common 
symptom of acute cholecystitis. Other common symptoms include fever, nausea, 
and vomiting. On physical exam, right upper quadrant tenderness and guarding 
are usually present inferior to the right costal margin, distinguishing the episode 
from simple biliary colic. 
  Ultrasound is the most useful radiographic test for diagnosing acute 
cholecystitis. It is sensitive for identifying the presence of gallstones. Biliary 
radionuclide scanning is used less frequently today but may be helpful in atypical 
cases. No filling of the gallbladder with the radiotracer (99mTc-HIDA) after 4 
hours indicates an obstructed cystic duct. 
  After the diagnosis of acute cholecystitis is made, IV fluids, antibiotics, 
and analgesia should be initiated. Antibiotics should cover gram-negative aerobes 
as well as anaerobes. Cholecystectomy is the definitive treatment for patients with 
acute cholecystitis. Early cholecystectomy performed within 2 to 3 days of 
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presentation is preferred over interval or delayed cholecystectomy that is 
performed 6 to 10 weeks after initial medical therapy. 
3) Choledocholithiasis 
Common bile duct stones are classified by their point of origin and are 
found in 6% to 12% of patients with stones in the gallbladder. Common duct 
stones are also defined as retained if they are discovered within 2 years of 
cholecystectomy, or recurrent if they are detected more than 2 years after 
cholecystectomy. The secondary stones are usually of the brown pigment type. 
The primary stones are associated with biliary stasis and infection and are more 
commonly seen in Asian populations. 
Common bile duct stones may be silent and are often discovered 
incidentally. In these patients, biliary obstruction is transient, and laboratory tests 
may be normal. Clinical features suspicious for biliary obstruction due to common 
bile duct stones include biliary colic, jaundice, lightening of the stools, and 
darkening of the urine. In addition, fever and chills may be present in patients 
with choledocholithiasis and cholangitis. 
Ultrasonography, commonly the first test, can document stones in the 
gallbladder and estimate the diameter of the common bile duct. A dilated bile duct 
(>8 mm in diameter) on ultrasonography in a patient with gallstones, jaundice and 
biliary pain is highly suggestive of choledocholithiasis. MRC provides excellent 
anatomic detail, with sensitivity and specificity of 95% and 98%, respectively. 
ERCP is the diagnostic and potentially therapeutic test of choice for patients with 
suspected common bile duct stones. 
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The use of endoscopic cholangiography in patients with suspected common 
bile duct stones not only confirms the diagnosis but also provides ductal clearance 
of the stones and sphincterotomy before subsequent laparoscopic 
cholecystectomy. Prompt cholecystectomy after endoscopic clearance of the 
common bile duct should be performed during the hospital admission if the 
patient is fit for surgery. 
Laparoscopic common bile duct exploration through the cystic duct or with 
formal choledochotomy allows the stones to be retrieved during the same 
procedure. If a choledochotomy is performed, a T tube is left in place. The 
purpose of the T tube is to provide access to the biliary system for postoperative 
radiologic stone extraction. 
4) Gallstone Pancreatitis 
Blockage of the pancreatic duct by an impacted stone or temporary 
obstruction by a stone passing through the ampulla may lead to pancreatitis by an 
unknown mechanism. An ERCP with sphincterotomy and stone extraction is the 
initial treatment and may relieve the pancreatitis. Once the pancreatitis has 
subsided, the gallbladder should be removed during the same admission. 
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3.9 INVESTIGATIONS 
To date there are no serum or other lab tests that are absolutely specific for 
the presence of gallstones. In acute cholecystitis due to gallstones patient will 
have leucocytosis. There may be mild elevation of transaminases and alkaline 
phosphatase. In CBD stones serum alkaline phosphatase will be elevated along 
with serum gamma glutamyltranspeptidase.[78] 
The following investigations can be broadly used in patients with gall stone 
diseases: 
1. Blood investigations. 
2.  Plain X-ray abdomen. 
3.  Oral Cholecystography. 
4.  Cholangiography. 
5.  Ultrasonography (USG). 
6.  Computed Tomography (CT). 
7.  Magnetic Resonance Cholangio Pancreatography (MRCP).  
8.  Endoscopic Retrograde Cholangio Pancreatography  (ERCP).  
9.  Hepatobiliary Scintigraphy. 
3.9.1 Laboratory tests 
Although termed liver function tests, the routine hepatic panel for most 
laboratories tests a number of aspects of metabolic and hepatic activity. The tests 
most useful for evaluation of biliary physiology include determination of levels of 
bilirubin, alkaline phosphatase, seen in any cholestatic process, and serum trans- 
aminases, suggesting evidence of hepatocellular injury. Bilirubin can be 
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subdivided into the conjugated and unconjugated forms, thereby allowing 
delineation of cause based on cellular location of derangement. In other words, 
hyperbilirubinemia may be caused by increased synthesis of bilirubin, impaired 
hepatocyte uptake of unconjugated bilirubin, decreased intracellular conjugation, 
reduced intracellular transport and excretion of conjugated bilirubin, or 
obstruction of the biliary tree. Although an oversimplification of a complex 
process, derangements up to and including conjugation will manifest as elevated 
unconjugated bilirubin levels[79]. 
3.9.2 Imaging modalities 
1) Abdominal x-ray 
Only 10% gallstones are radiopaque and can be visualized on a plain X-
Ray of the abdomen. Thus plain radiograph is not very sensitive for gall stones. 
2) Oral cholecystography 
For years this test was the mainstay and gold standard for the diagnosis of 
gallstone though now it has been replaced by USG except where function of the 
gallbladder has to be assessed. Cholecystography is more accurate than USG in 
terms of quantification of the number of stones and their sizes[80]. The sensitivity 
for detection of radiolucent stones exceeds 90% but visualization of the ductal 
stones is obtained in only 20%.[81] 
3) Abdominal USG 
This is the preferred investigation for suspected cholelithiasis or 
cholecystitis. Examination should be performed after overnight fast of 8 to 12 
hours. Two types of transducers are used, 3.5 MHZ for most of the patients. 5 
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MHZ provides superior imaging resolution and can be used in obese patients. 
Major signs of diagnosis of acute cholecystitis are demonstration of gallstones or 
edema or gas in the gallbladder wall. Non visualization of the gallbladder is also a 
major sign. Simple wall thickening is a minor sign as is local tenderness, a round 
shaped or dilatation. Pericholecystitic fluid is also a minor sign. The 
demonstration of major and minor sign together gives an overall accuracy of over 
90%.When the gallbladder is normal, ultrasound often indicates other pathologies. 
In chronic cholecystitis the wall is also thickened but lacks the echo poor 
halo and there is no local tenderness. The gallbladder fails to empty after a meal 
or CCK Challenge. Stones are usually present. A mucocele appears as a large, 
sometimes enormous gallbladder which is non tender and thin walled. The 
contents are usually echo free, apart from stones, though debris may form. 
In general ultrasonography has distinct advantages over conventional oral 
cholecystography. These include absence of radiation exposure, independent of 
patient compliance and the lack of requirement for an intact digestive and hepatic 
system. In addition to identifying stones within the gallbladder or bile duct, 
abdominal ultrasonography provides important ancillary information regarding 
the anatomy of bile ducts, pancreas, and other structures in the upper abdomen. 
The newer techniques of sonography include the endoscopic ultrasonography. It is 
more sensitive in identifying small gallstones and also common bile duct stone. 
Endoscopic ultrasonography is useful for detecting small gallbladder stones 
missed on transabdominal imaging, especially those located in the neck of the 
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gallbladder, where duodenal gas can obscure the image when scanning 
percutaneously. 
Sensitivity of USG to detect cholelithiasis is 95-99%. They are seen as 
echogenic foci with accousting shadowing and move with change in posture. This 
can detected the gallstones of about 1mm in size. The difficulty in USG is its 
limitation in measuring large gallstones and quantifying multiple gallastones.[82] 
4) CT Scan[83] 
Although ultrasound is clearly the first test of choice for delinea- tion of 
biliary pathology, computed tomography (CT) provides superior anatomic 
information. Because most gallstones are radiographicallyisodense to bile, many 
will be indistinguishable from bile. However, because ultrasound is operator-
dependent nd provides no anatomic reconstruction of the biliary tree, CT can be 
used to identify the cause and site of biliary obstruction. When performed for the 
evaluation of hepatic or pancreatic parenchyma or possible neoplastic processes, 
CT is invaluable in preoperative planning, and the use of arterial phase, portal 
venous phase, and delayed phase imaging, known as a triple-phase CT, has 
essentially replaced diagnostic angiography of the liver. 
5) MRI and MRCP 
Magnetic resonance imaging (MRI) uses the water in bile to delineate the 
biliary tree and thus provides superior anatomic definition of the intrahepatic and 
extrahepatic biliary tree and pancreas. Although management of most patients 
with biliary pathology does not require the fine detail of anatomic evaluation 
shown by cross-sectional imaging, MRI is noninvasive, requires no radiation 
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exposure, and can prove extremely useful when planning resection of biliary or 
pancreatic neoplasms or management of complex biliary pathology[84]. By using 
the water content of bile, a cholangiopancreatogram can be created. 
6) ERCP 
Endoscopic retrograde cholangiopancreatography (ERCP) is an invasive 
test using endoscopy and fluoroscopy to inject contrast through the ampulla and 
image the biliary tree. Although it does carry a complication rate of up to 10%, its 
usefulness lies in its ability to diagnose and treat many diseases of the biliary tree. 
For patients with malignant obstruction, ERCP can be used to provide tissue 
samples for diagnosis while also decompressing an obstruction, but does not stage 
patients accurately. Many benign diseases, such as choledocholithiasis, can be 
easily treated by endoscopic means. ERCP has also proven extremely useful in the 
diagnosis and treatment of complications of biliary surgery[85]. 
7) Hepatic Iminodiacetic Acid Scan 
Although incapable of providing precise anatomic delineation of 
pathophysiology, biliary scintigraphy, also known as a hepatic iminodiacetic acid 
scan (HIDA) scan, can be used to evaluate the physiologic secretion of bile. The 
injection of an iminodi- acetic acid, which is processed in the liver and secreted 
with bile, allows identification of bile flow. Therefore, the failure to fill the 
gallbladder 2 hours after injection demonstrates obstruction of the cystic duct, as 
seen in acute cholecystitis. In addition, the scan will identify obstruction of the 
biliary tree and bile leaks, which may be useful in the postoperative setting. HIDA 
scans can also be used to determine gallbladder function, because the injection of 
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CCK during a scan will document physiologic ejection of the gallbladder. This 
may be useful in patients with biliary tract pain but without stones, because some 
patients have pain from impaired emptying, known as biliary dyskinesia. As a 
nuclear medicine test, the test demonstrates physiologic flow, but does not 
provide fine anatomic detail, nor can it identify gallstones[86]. 
8) Cholangiography: 
Routine cholangiography during laparoscopic cholecystectomy has been 
advocated to confirm anatomy and thus prevent ductal injury. An intra operative 
cholangiography provides a “road map” of entire biliary system and aids in the 
dissection of the function between cystic and common bile ducts which is of great 
value in cases where anatomic land marks are not clearly identified or where 
variation to the normal ductal anatomy are present[87]. 
3.10 TREATMENT[88] 
There are various treatment available for treatment of gallstones. 
Nevertheless, cholecystectomy remains the gold standard. 
Non invasive treatment of gallstones 
1. Oral dissolution therapy 
2. Extracorporeal shock wave lithotripsy. 
Minimally invasive gallbladder procedure 
1. Percutaneous cholecystostomy 
2. Contact dissolution therapy 
3. Percutaneous cholecystolithotomy 
4. Laparoscopic cholecystectomy 
Invasive procedure 
1. Open cholecystectomy. 
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LAPAROSCOPIC CHOLECYSTECTOMY 
Following the advent of laparoscopic surgery, with its accompanying 
smaller incisions, less pain, and shorter hospitalization, surgeons have performed 
an increasing number of laparoscopic cholecystectomies. Acute cholecystitis 
carries longer operative times and a higher conversion rate to the open procedure 
than when laparoscopic cholecystectomy is performed in the elective setting. 
General anesthesia with muscle relaxation is required when performing a 
laparoscopic cholecystectomy,. Therefore, one contraindication to the procedure 
is the inability to tolerate general anesthesia. Others include end-stage liver 
disease with portal hypertension, precluding safe portal dissection, and 
coagulopathy. Because most pneumoperitoneum laparoscopy is performed using 
CO2 and has a number of adverse physiologic effects, severe chronic obstructive 
pulmonary disease, with poor ability for gas exchange, and congestive heart 
failure are considered relative contraindications[33]. 
Patient preparation, induction of anesthesia, and sterile draping are 
performed as for an open cholecystectomy. Although use of a urinary catheter 
depends on the clinical setting, an orogastric tube is standard to decompress the 
stomach and help with exposure of the upper abdomen. Access to the peritoneal 
cavity and creation of pneumoperitoneum can be performed by the open or closed 
technique according to the expertise and discretion of the surgeon. The open 
technique involves making a small incision at the umbilicus, cutting down through 
the fascia of the abdominal wall, incising the peritoneum directly, and inserting a 
blunt trocar, known as a Hasson cannula. Alternatively, in the closed technique, 
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an incision is made and a needle inserted into the peritoneal cavity to insufflate 
the abdomen prior to the placement of any trocars. Following the establishment of 
a CO2 pneumoperitoneum, a brief exploration is performed and additional 5-mm 
ports are placed in the right anterior axillary line, right midclavicular line, and 
subxiphoid location. The lateral port at the anterior axillary line is used to elevate 
the fundus of the gallbladder toward the right shoulder. This retraction provides 
exposure to the infundibulum and porta hepatis. The midclavicular trocar is used 
to grasp the gallbladder infundibulum, retracting it inferolaterally to open the 
triangle of Calot By distracting Hartmann’s pouch laterally, the cystic duct no 
longer lies almost parallel to the common hepatic duct. 
The dissection is then carried along the infundibulum on the anterior and 
posterior surfaces to expose the base of the gallbladder. This dissection will 
eventually clear all fibrofatty tissue from the triangle of Calot. Inferolateral 
traction of the infundibulum then allows documentation of two structures entering 
the gallbladder, the cystic duct and cystic artery. A useful landmark for the cystic 
artery is the overlying lymph node, known as Calot’s node. The view of the liver 
bed through the space between cystic duct and cystic artery and above the cystic 
artery is known as the critical view of safety, and minimizes the risk of 
inadvertent iatrogenic bile duct injury. With sufficient dissection, clips are placed 
on the cystic artery and cystic duct. If a cholangiography is performed, the cystic 
duct is only clipped adjacent to the gallbladder and the cystic duct incised, 
although not transected. A cholangiographic catheter is then fed through the 
incised duct and fluoroscopic images obtained with injection of contrast into the 
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cystic duct and biliary tree. On obtaining a normal cholangiogram or when 
cholangiography is not performed, the cystic duct is doubly clipped on the 
common duct side and transected. The previously clipped artery is also transected 
and the gallbladder dissected off the liver bed using electrocautery. Because the 
venous drainage of the gallbladder is directly into the liver bed through venules, 
excellent hemostasis must be achieved during this dissection. The cystic duct and 
cystic artery clips are inspected just prior to completion of the dissection of the 
fundic attachments, because the superior traction of the fundus has provided 
exposure to the porta and triangle of Calot. The gallbladder is then brought out of 
the abdominal cavity through the umbilical port. In the setting of acute 
cholecystitis, or if during dissection the gallbladder was entered, a plastic bag 
should be used for retrieval. Any stones that are spilled during a cholecystectomy 
should also be retrieved. 
Opinion is sharply divided regarding the performance of selective versus 
routine cholangiography, with supportive data for each approach. Routine 
cholangiography will identify unsuspected stones in less than 10% of patients and 
the natural history of these asymptomatic stones suggests that they will remain 
asymptomatic. Iatrogenic bile duct injury occurs less often when cholangiography 
is performed routinely. However, even when performed routinely, 
cholangiograms are frequently misinterpreted and thus do not adequately prevent 
an injury. In many cases of laparoscopic cholecystectomy performed for biliary 
colic, a cholangiogram will not alter management. Also, it increases the operative 
time and adds fluoroscopic exposure. Indications for cholangiography in the 
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selective setting include unexplained pain at the time of cholecystectomy, any 
suspicion of current or previous choledocholithiasis without pre-operative duct 
clearance, any question of anatomic delineation during cholecystectomy, elevated 
preoperative liver enzyme levels, dilated common bile duct in preoperative 
imaging, and suspicion of intraoperative biliary injury. 
 Although just as accurate as cholangiography for the identification of 
choledocholithiasis, laparoscopic ultrasonography is highly operator- dependent, 
requires additional instrumentation, and is not widely available. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Laparoscopic cholecystectomy ports. the assistant uses the 
periumbilical port to provide access for the camera and the most lateral port to 
elevate the fundus and expose the neck. the surgeon can then provide inferolateral 
traction on the infundibulum and open the critical view of safety. 
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OPEN CHOLECYSTECTOMY 
As laparoscopic cholecystectomy has become the procedure of choice for 
the treatment of most gallbladder disease, experience with open cholecystectomy 
has drastically declined. Open cholecystectomy is generally performed following 
conversion from the laparoscopic approach or as a step during another operation, 
such as a pancreaticoduodenectomy. The open cholecystectomy can be performed 
through a midline or right subcostal incision. Retraction of segment IV provides 
exposure of the cystic duct and artery. With similar inferolateral traction to the 
gallbladder infundibulum, the cystic duct is taken out of alignment from the 
common duct for its identification and division. Early identification and ligation 
of the cystic artery limits the blood loss during the procedure, but may prove 
difficult because of inflammation.  
Another approach to the gallbladder infundibulum involves dissecting the 
fundus off the liver in a dome- down approach. Here, the attachments of the 
gallbladder are divided, allowing inferolateral traction of the entire gallbladder to 
open the triangle of Calot and identify the appropriate duct and artery. When 
performed for severe cholecystitis, the dissection of the gallbladder of the liver 
bed may be associated with sub- stantial blood loss, but with removal of the 
infected gallbladder and packing of the area, the bleeding is usually well 
controlled. 
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MATERIALS AND METHODS 
50 patients suffering from Cholelithiasis, confirmed by USG, were divided 
into two groups based on serum iron values. Group A, consists of patients with 
normal serum iron (non-anaemic) and group B, of patients with less than normal 
serum iron (anaemic). Gall bladder Bile cholesterol and serum cholesterol of both 
the groups are compared. 
TYPE OF STUDY  : Cross Sectional Study 
SAMPLE SIZE   : 50 patients 
PERIOD OF STUDY : Dec 2014 - Sep 2015 
PLACE OF STUDY :  
 Department of General Surgery at Government Royapettah Hospital, 
Kilpauk Medical College Hospital, Chennai. 
4.1 MATERIALS AND METHODS: 
The study was conducted over a period of 10 months, from December 
2014- September 2015. The study protocol was approved by the ethical committee 
of our institute. It was a retrospective analysis. The patients were selected, based 
only on the USG confirmation of their gall stones, irrespective of their age, sex, 
physique, parity, etc. Only those patients were included, whose serum as well as 
bile could be procured for analysis. Patients with empyema and mucocele of gall 
bladder were excluded. 
All the patients, who were included in the study were given a serial number 
1 to 50, in the order of their admission to the surgery department for 
Cholecystectomy. Thus their bile and serum samples were also labeled 1 to 50 
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accordingly. The numbered samples were sent to the Biochemistry department for 
analysis. All the numbered samples with less than normal serum iron (n=23) were 
put in the anaemic group, B and all the samples with normal serum iron (n=27) 
were put in the non anaemic group, Group A. 
Serum iron was estimated by Ferrozine kit method for determination of 
iron. The normal reference values supplied with the kit, for males (60-160 μg/dl) 
and for females (35-145 g/dl), were used to label the patients as anaemic and non-
anaemic i.e. males with serum iron < 60 g/dl and females with serum iron <35 
μg/dl were labeled as anaemic. During the operation for open cholecystectomy, 
bile was aspirated with an aspiration needle mounted on a sterilized syringe. The 
aspiration needle was passed obliquely into the fundus of gall bladder and as 
much of bile as possible, was withdrawn from the gall bladder. Similarly during 
laparoscopic cholecystectomy, bile was aspirated under vision through a long 
venflon needle or a veress needle just before delivering out the gallbladder at the 
port site. Bile was kept in a sterile labeled container and sent for analysis. Serum 
cholesterol and gall bladder bile cholesterol of all the patients were estimated. 
Bile was first subjected to the Folch method to extract lipids and then the 
cholesterol contents were estimated as for serum cholesterol. In the Folch method, 
lipids from bile were extracted by using water, Methanol and Chloroform mixture 
in the ratio of 3:4:8 v/v and from the extracted lipids, cholesterol was estimated by 
Enzopak kit, based on the cholesterol oxidase/peroxidase method. The enzymes 
used only the cholesterol as substrate and hence Bilirubin is automatically 
eliminated, from the procedure of cholesterol estimation. 
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4.2 ANALYSIS: 
• The biliary cholesterol levels in the 2 groups of patients A and B were 
compared using a student t-test to detect any statistically significant 
difference. 
• Similarly, the serum cholesterol levels of these 2 groups were analyzed 
with a student t-test. 
• Also, the age, sex and parity distributions of serum iron and biliary 
cholesterol in the study population was analyzed. 
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RESULTS 
 During the 10 month period from Dec 2014 to September 2015, a 
comparative study of Biliary Cholesterol levels was done between 2 groups, 
divided based on Serum Iron levels among 50 consecutive patients admitted to the 
Department of Surgery, Govt. Royapettah Hospital, Kilpauk Medical College, 
Chennai with a diagnosis of Symptomatic Gallstone Disease who underwent 
Cholecystectomy. The results are as follows: 
 Out of the 50 Patients, 40 (80%) were female and 10 (20%) were males. 
  The Male to Female Ratio was 1:4. 
  In the present study the minimum age was 17 yrs and the maximum age 
was 68 yrs. 
  The number of patients was highest in the age group of 40-50 yrs having 
14 patients (28%) followed by 30-40 yrs having 13 patients (26%). The 
least was in the age group 60-70 and 0-20 yrs having 2 patients each (4%). 
  Mean age was 40.6 yrs. Standard Deviation 12.1 yrs 
  Median Age was  39.5 yrs. 
 The Majority of Patients Presented with all the 3 symptoms of 
cholelithiasis—31(62%) of the 50. 
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Table 1. Age Distribution of the Study Group: 
Age Range Frequency Percentage 
<20 yrs 2 4% 
20-30 yrs 11 22% 
30-40 yrs 13 26% 
40-50 yrs 14 28% 
50-60 yrs 8 16% 
60-70 yrs 2 4% 
Total 50 100% 
 
Chart 1. Age Distribution of Study Population 
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Table 2. Sex Ratio of the Study Group: 
 Male Female 
10 40 
 
Chart 2. Sex Ratio of Study Group 
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Table 3.  Combined Age and Sex distributions: 
Age Range Total Females Males 
<20 yrs 2 2 0 
20-30 yrs 11 10 1 
30-40 yrs 13 10 3 
40-50 yrs 14 12 2 
50-60 yrs 8 5 3 
60-70 yrs 2 1 1 
>70 yrs 0 0 0 
 
Chart 3.  Combined Age and Sex Distributions: 
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Results of the Analytical Study: 
 The 50 Patients, who were Gall Stone Sufferers were divided into 2 Groups 
based on the serum Iron levels. 
Group A: Patients with normal serum iron.  
          (M: 60-160 μg /dl  F: 35-145 μg /dl) 
Group B: Patients with less than normal serum iron. 
 27 (54%) of them were in the Normal Iron Deficient Group (A) and 23 
(46%) were in the Iron Deficient Group (B). 
 The Non Iron-Deficient patients (n=27)-Group A: 
*The average serum iron was 93.2± 35 micro gm/dl. 
* The Mean Biliary Cholesterol Level was  
           MEAN=754.5 mg/dl    SD=398.3 mg/dl 
*The Mean Serum Cholesterol Levels were 184.8 ±35 mg% 
 The Iron-Deficient patients (n=23)-Group B: 
*The average serum iron was 26.8± 8.6 micro gm/dl. 
* The Mean Biliary Cholesterol Level was  
                  MEAN=1184.7 mg/dl      SD=405.2 mg/dl 
* The Mean Serum Cholesterol Levels were 172±49 mg% 
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Table 4.  
Distribution of patients into Group A and Group B: 
 
Group A 
(Non-Iron Deficient) 
Group B 
(Iron Deficient) 
27 23 
 
Chart 4. Distribution of patients into Group A and Group B: 
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Table 5.  Serum Iron Levels in Study Group Patients: 
Patients No. % Range of 
Serum Iron 
(μg/dl) 
Mean ±S.D 
Males 
• Non-Iron Deficient 
• Iron Deficient 
• Total 
  
9 
1 
10 
  
90 
10 
100 
  
95.5-163 
40 
95.5-163 
  
119.8 ± 25.3 
- 
111.8 ± 34.7 
Females 
• Non-Iron Deficient 
• Iron Deficient 
• Total 
  
18 
22 
40 
  
45 
55 
100 
  
36.3-140.1 
7.4-34.6 
7.4-140.1 
 
79.8 ± 31.1 
26.2 ± 8.3 
50.4 ± 34.5 
 
Chart 5. Sex Distribution among Groups 
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Chart 6. Group A & B Distribution among Males and Females 
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Table 6. Serum Iron Contents in Group A & Group B Patients 
Group No. of Patients Serum Iron 
Range μg/dl 
Serum Iron 
Mean ±S.D 
A (Non-Iron 
Deficient) 
27 36-163  93.2 ± 34.6 
B (Iron deficient) 23 7-40 26.8 ± 8.6 
P-Value   <0.0001 
 
Chart 7. Mean Serum Iron Contents + Standard Deviation in  
Group A & Group B Patients 
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Table 7.  Biliary Cholesterol Levels in Group A & Group B Patients 
Group No. of 
Patients 
Biliary Cholesterol 
Range mg/dl 
Biliary 
Cholesterol 
Mean ±S.D 
A (Non-Iron Deficient) 27 3-147 754.5 ± 398.3 
B (Iron deficient) 23 26-181 1184.7 ± 405.2 
P-Value   <0.0004 
 
 
Chart 8. Mean Biliary Cholesterol Levels + Standard  
Deviation in Group A & Group B 
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Table 8. Serum Cholesterol Levels in Group A & Group B Patients 
 Group No. of 
Patients 
Serum Cholesterol 
Range mg/dl 
Serum Cholesterol 
Mean ±S.D 
A (Non-Iron 
Deficient) 
27 93-254 184.8 ± 35 
B (Iron deficient) 23 79-270 171 ± 49.3 
P-Value   0.2544 
 
Chart 9. Mean Serum Cholesterol Levels + Standard  
Deviation in Group A & Group B 
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Table 9. Serum Iron, Biliary Cholesterol and Serum  
Cholesterol Levels with P- Values after T- Test Analysis 
 
Groups Serum Iron 
(μg/dl) 
Biliary 
Cholesterol 
(mg/dl) 
Serum Cholesterol 
(mg/dl) 
A=27  
(Non- Iron Deficient) 
93.2 ± 34.6 754.5 ± 398.3 184.8 ± 35 
B=23 (Iron Deficient) 26.8 ± 8.6 1184.7 ± 405.2 171 ± 49.3 
P-Value <0.0001 
Extremely 
Significant 
<0.0004 
Extremely 
Significant 
0.2544 
Not Significant 
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INDIVIDUAL UNPAIRED T- TEST ANALYSIS: 
 
 BILIARY CHOLESTEROL LEVELS: 
Group Group A (Non- Iron 
Deficient) 
Group B (Iron 
Deficient) 
Mean Biliary Cholesterol 754.500 1184.700 
SD 398.300 405.200 
SEM 76.653 84.490 
N 27 23 
 
 P value and statistical significance: 
   The two-tailed P value equals 0.0004 
By conventional criteria, this difference is considered to be extremely 
statistically significant.  
 Confidence interval: 
   The mean of Group One minus Group Two equals -430.200 
   95% confidence interval of this difference: From -659.252 to -201.148  
 Intermediate values used in calculations: 
   t = 3.7763 
   df = 48  
   standard error of difference = 113.920 
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 SERUM CHOLESTEROL LEVELS: 
Group Group A 
(Non- Iron Deficient) 
Group Two (Iron 
Deficient) 
Mean Serum Cholesterol 184.800 171.000 
SD 35.000 49.300 
SEM 6.736 10.280 
N 27 23 
 
 P value and statistical significance: 
   The two-tailed P value equals 0.2544 
By conventional criteria, this difference is considered to be not statistically 
significant.  
 Confidence interval: 
The mean of A (Non-Iron Deficient) minus B (Iron Deficient) equals 
13.800 
   95% confidence interval of this difference: From -10.254 to 37.854  
 Intermediate values used in calculations: 
   t = 1.1535 
   df = 48 
 standard error of difference = 11.963  
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PARITY SPECIFIC DISTRIBUTION: 
 All the female patients were subdivided based on their parity status. 
 31 (77.5) of the 40 female patients were multiparous. 
 The Multiparous Females in Groups A and B were 12 and 19 respectively. 
 The Primiparous Females in Groups A and B were 4 and 2 respectively. 
 The Nulliparous Females in Groups A and B were 2 and 1 respectively. 
 This show that multiparous females predominant in the iron deficient 
group. 
Table 10. Parity specific distribution of Serum Iron Levels in Female Patient 
 
 
 
 
 
 
 
 
Parity  Group 
A 
Non Iron-
Deficient 
 Group B Iron 
Deficient 
 No of Pts % Mean Serum 
Iron 
No. of Pts % Mean Serum 
Iron 
Nulliparous 2 11 120.6 ± 27.5 1 4.5 34 
Primiparous 4 22 89.3 ± 25.2 2 9 33 ± 1 
Multiparous 12 67 69.9 ± 28.5 19 86.5 25.1 ± 8.4 
Total 18 100 79.8 ± 31.1 22 100 26.2 ± 8.3 
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Chart 11. Parity specific distribution of Serum Iron Levels in Female Patient 
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DISCUSSION 
Cholelithiasis is a very common condition encountered in surgical practice. 
Though most cases may be asymptomatic, a definitive percentage of these patients 
may develop symptoms of Gall Stone disease. A few will develop complications 
that may even be life threatening. 
Over the past century the mortality and morbidity related to Gall Stone 
Disease has decreased due to the early recognition and treatment of symptomatic 
cholelithiasis. By and large, surgical management has been the treatment of 
choice, and with the advent of laparoscopy, Laparoscopic cholecystectomy has 
replaced Open Cholecystectomy  as the Gold Standard in the surgical 
management of uncomplicated gall stone disease. 
There have been numerous studies done to assess the risk factors for 
Cholelithiasis. These have been discussed earlier in this study. Also its of 
paramount importance to identify easily modifiable risk factors as these can help 
in risk stratification and also prevention. 
The exact mechanism of Gall Stone formation is a complex process that is 
not solely dependent on any single factor. Thus Gall stone disease has a multi 
factorial etiology. Newer risk factors/ etiological agents have been studied time 
and again, with some showing to have a significant impact on the disease process. 
As stated already, animal studies had suggested that Iron may have a role 
to play in the pathophysiology of gall stone disease. More importantly the finding 
that iron deficient mammals were more prone to develop gall stones, has sparked 
interest in its probable role in humans. Also the classical teaching is that a 
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females, in her forties, obese and multiparous is more prone for gall stone disease. 
When this is viewed, keeping the recent findings in perspective, it may suggest 
that apart from the other risk factors in this group, these are also the patients who 
are most iron deficient. Hence, it makes perfect sense, more so in the Indian 
population, to define the role of Iron or its deficiency in the pathophysiology of 
gall stone disease. 
As data from other studies suggest, Iron deficiency changes the activity of 
many liver enzymes. This may be a factor in promoting cholesterol 
supersaturation and increased cholesterol crystal nucleation. Also Iron acts as a 
coenzyme for nitric oxide synthase. Nitric oxide helps in the normal gall bladder 
tone and relaxation. An alteration in this fine balance may promote gallbladder 
stasis which results in cholesterol stone formation. 
The current study was done in a randomly selected South Indian 
Population who presented to our hospital with symptomatic gall stone disease. 
Demographic Distributions: 
 SEX: 
• Of the 50 patients with gall stone disease, 40 were females (80%) and 10 
were males(20%). This is consistent with the known sex prevalence, that 
gall stone disease is more common in females than males.  
• The main sufferers of gall stone disease in our study were females as 
compared to males. The female to male ratio was 4:1. This was similar to 
that observed in his study by Zuhair R, Ganey et al.[89] and Major Alok 
Sharma et al, series . In contrast, this was higher than that observed by 
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Frazee et al[90],U.Berggren et al[91] and the Battacharyaseries.This is higher 
than that reported by most western studies indicate the female to male ratio 
as between 3:1 to 2:1.  
• The reason for high incidence in females could be that pregnancy and child 
birth have a direct influence on biliary tract disease, acting by bile stasis , 
weight gain and consequently hypercholesteremia. 
 AGE: 
• The maximum number of patients-14  (28%) of the 50- were in the age 
group of 40-50 yrs followed by 30-40 yrs having 13 patients (26%). 
The Mean age was 40.6 yrs SD-12.1 yrs. 
• Similar incidence is seen in the studies of Herman et al and Hanif series 
showed peek incidence in 5th decade.  
• In western studies the peak incidence is in the 5th and 6th decades. 
Similar findings are noted in the studies of Ganey et al[89] and Moreaux 
et al[92]. 
 GROUP DIVISIONS: 
• The 50 patients were divided based on their serum iron levels into 2 
groups.  
Group A- Non Iron Deficient  
Group B- Iron Deficient 
• In both the groups, females predominated more than males. 
Group A= M:F=1:2 
Group B=M:F=1:22 
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• Female patients far exceeded males in the iron deficient group (Group B), 
consistent with the fact that iron deficiency is more prevalent in females. 
 PARITY DISTRIBUTION: 
• The 40 females, both Group A (18) and B (22) were divided based on 
parity. In both the groups A and B the number of multiparous females 
[n(A)=12,n(B)=19] who suffered from cholelithiasis was more than 
primipara [n(A)=4,n(B)=2] and nullipara [n(A)=2, n(B)=1] 
 
CRITICAL REVIEW OF TEST STATISTICS: 
* The non-Iron deficient group (Group A) had an above average value of  
93.2 ± 34.6 micro gm/dl as compared to the Iron deficient group (Group B) 
which had a value of 26.8 ± 8.6 micro gm/dl. 
* The Biliary Cholesterol values for Group A and B respectively were 
754.5 ± 398.3 and 1184.7 ± 405.2 mg/dl. 
*  The Serum Cholesterol values for Group A and B respectively were 184.8 
± 35 and 171 ± 49.3 mg/dl. 
 In our study the Biliary Cholesterol levels were significantly higher in the 
Iron Deficient group (Group B) than compared to the Non-Iron Deficient 
Group. This result was extremely statistically significant with a p value of 
<0.0004. 
 Also, there was no significant difference between the values of serum 
cholesterol levels in the Iron Deficient (Group B) and Non-Iron  Deficient 
Group. (Group A). P value of 0.2544. 
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The current study suggests that deficiency in serum iron could play a role 
in the increased saturation of biliary cholesterol. Biliary cholesterol 
supersaturation is an independent factor in the formation of cholesterol gall 
stones. As mentioned previously, the probable explanation for this is the defective 
cholesterol metabolism and gall bladder stasis promoted a deficiency in serum 
iron. 
  
 
 
 
 
CONCLUSION 
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CONCLUSION 
 To conclude, there was a significant difference in the Biliary Cholesterol 
Levels for Non-Iron Deficient (M=754.5 mg/dl , SD=398.3) and Iron 
Deficient  Subjects(M=1184.7 mg/dl, SD=405.2)  t=3.77, p =<0.0004. 
 
 Similarly, an independent t-test comparing Serum Cholesterol levels in 
Non-Iron Deficient (184.8 ± 35 mg/dl) and Iron Deficient subjects (171 ± 
49.3 mg/dl) did not find a statistically significant difference. (p=0.2544) 
 
These results suggest that Iron Deficiency has an association with Biliary 
Cholesterol Values. 
  
  
 
 
 
 
SUMMARY 
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SUMMARY 
1.  The Study was done on 50 consecutive patients with Gall Stone disease 
who were operated in our department. 
2.  In this study, 40 patients (80%) were female and 10 patients (10%) were 
male. 
3.  In this study, maximum patients were from age group 40 – 50 years who 
accounted for 28 % (14 patients) followed by 30 – 40 years age group, 13 
patients (26%). The least number of patients in the 60 – 70 and 0-20 years 
age group-2 patients each (4%). 
4.  The Mean age is 40.6 yrs with SD 12.1 yrs. Median Age was 39.5 yrs. 
5.  After the 50 patients were divided based on Serum Iron Levels 27 (54%) of 
them were in the Normal Iron Deficient Group (A) and 23 (46%) were in 
the Iron Deficient Group (B).  
6.  Female patients far exceeded males in the iron deficient group. In both the 
groups A and B the number of multiparous females who suffered from 
cholelithiasis was more than primipara and nullipara. 
7.  In The Non Iron-Deficient patients (n=27)-Group A: 
 * The average serum iron was 93.2± 35 micro gm/dl. 
 *  The Mean Biliary Cholesterol Level was  
   MEAN=754.5 mg/dl    SD=398.3 mg/dl 
 * The Mean Serum Cholesterol Levels were 184.8 ±35 mg% 
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8.  In the Iron-Deficient patients (n=23)-Group B: 
 * The average serum iron was 26.8± 8.6 micro gm/dl. 
 *  The Mean Biliary Cholesterol Level was  
   MEAN=1184.7 mg/dl      SD=405.2 mg/dl 
 * The Mean Serum Cholesterol Levels were 172±49 mg% 
 
9.  The Biliary Cholesterol values for Group A and B respectively were 754.5 
± 398.3 and 1184.7 ± 405.2 mg/dl. 
10. The Biliary Cholesterol levels were significantly higher in the Iron 
Deficient group (Group B) than compared to the Non-Iron Deficient 
Group. This result was extremely statistically significant with a p value of 
<0.0004. 
Patients with gall stone disease and low Serum Iron have higher values of 
biliary cholesterol, possibly implicating the role of Serum Iron in the pathogenesis 
of cholesterol gall stones. 
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PROFORMA 
 
NAME:                                    DATE OF ADMISSION: 
 
AGE    :                                    DATE OF DISCHARGE: 
 
 
SEX     :                                    ADDRESS: 
 
 
IP NO. 
 
 
OCCUPATION: 
 
 
 
CHIEF COMPLAINTS: 
 
 
 
 
PAST HISTORY : 
 
 
 
 
PERSONAL HISTORY: 
 
 
 
FAMILY HISTORY: 
 
 
GENERAL EXAMINATION: 
 
PULSE:BP:TEMPERATURE: 
 
 
EXAMINATION OF ABDOMEN: 
 
 
INVESTIGATIONS: 
 
HB :TC:DC: 
 102 
 
BLOOD UREA:SERUM CREATININE: 
 
LFT: 
 
 
SERUM IRON LEVELS: 
 
 
SERUM LIPID PROFILE (Total Cholesterol): 
 
BILIARY LIPID PROFILE (Total Cholesterol): 
 
 
USG ABDOMEN: 
 
 
 
OTHER INVESTIGATIONS: 
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CONSENT FORM 
 
 
 
  
  
 
 
 
 
 
MASTER CHART 
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KEY TO MASTER CHART 
 
ABBREVIATIONS USED: 
 
 
Column Data Interpretation 
Sex 
M 
F 
 
Male 
Female 
Parity 
Null 
Primi 
Multi 
N/A 
 
Nulliparous 
Primiparous 
Multiparous 
Not-Applicable 
Serum Iron Levels Measured in Micro gm/dl 
 
Biliary Cholesterol Levels Measured in Milli gm/dl 
Serum Cholesterol Levels Measured in Milli gm/dl 
Study Group 
A 
B 
 
Non-Iron Deficient Group 
Iron Deficient Group 
 
 
Normal Iron Range criteria used in 
Study 
Males (60-160 μg/dl)  
Females(35-145 g/dl) 
 
